2篇
您的检索式：作者名="Dilan Demir"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Emergency department overcrowding:causes and solutions显示文摘Background:Emergency department(ED)overcrowding is among the biggest and most important problems experienced by ED staff.The number of ED visits is on the increase and remains an unresolved problem.Emergency department overcrowding has become an important problem for emergency care services worldwide.There is a relationship between overcrowding and patients’negative experi-ences of using ED and therefore reporting reduced patients’satisfaction.This study aimed to identify the causes of ED overcrowding,de-termine the reasons for people’s use of EDs,and develop solutions for reducing ED overcrowding.Methods:This study used quantitative methods using a descriptive approach.The participants were patients who visited the ED.A questionnaire was administered to 296 participants between December 2021 and February 2022.The study included 5 different hospitals in Turkey.The data were analyzed using descriptive statistics.Results:This study identified the most common presenting medical problems in the ED and why patients used the ED.Reasons for using the ED included patients perceiving their condition as really urgent(62.8%),the ED being open for 24 hours(36.1%),and receiving faster care in the ED(31.4%).This study also developed recommendations for alleviating ED overcrowding.Conclusion:This study identified causes of ED overcrowding and some solutions for alleviating the issue.Emergency department over-crowding should be perceived as an international problem,and initiatives for solutions should be implemented quickly. | Ahmet Butun Elif Ece Kafdag Hilal Gunduz Vedat Zincir Mehmet Batibay Kubra Ciftci Dilan Demir Ramazan Bayram Elanur Yigit | 2023 | Emergency and Critical Care Medicine2023，3，4： | 0 |
| 2 | Frequency and safety of COVID-19 vaccination in children with multisystem inflammatory syndrome:a telephonic interview-based analysis显示文摘Coronavirus disease 2019(COVID-19)vaccines are currently approved or authorized to prevent serious outcomes,such as severe disease,hospitalization,and death.The Pfizer-BioNTech vaccine is recommended for everyone aged five and older in the United States(US)to prevent severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection[1,2].However,it is unclear whether children with a history of multisystem,inflammatory syndrome in children(MIS-C)may be at risk for a MIS-like response following COVID-19 vaccination or SARS-CoV-2 reinfection[2].Therefore,physicians remain uncertain about vaccinating children with a history of MIS-C.This study investigates the occurrence of severe,systemic side effects of COVID-19 vaccines and the recurrence of the MIS-C symptoms in children with a history of MIS-C to overcome vaccine hesitancy. | Kubra Aykac Kubra Ozturk Osman Oguz Demir Dilan Demir Gumus Sevgi Aslan Ela Cem Miray Yilmaz Celebi Mustafa Dogan Karabacak Gulsum Alkan Fatma Dilsad Aksoy Burcu Ceylan Cura Yayla Eda Kepenekli Solmaz Celebi Melike Emiroglu Ilker Devrim Ali Bulent Cengiz Mehmet Ceyhan Yasemin Ozsurekci | 2022 | World Journal of Pediatrics2022，18，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员